In medtech, the person who wants the device rarely buys it. A surgeon can champion a product for months, and the decision still passes to a hospital value analysis committee that weighs clinical evidence against cost, with supply chain, finance and nursing at the table.
This page covers what a medtech manager coaches on a rep's live deal. It applies our discovery call guide to hospital selling, because most device deals are won or lost in what the rep learned before the committee met. The examples are invented. We do not publish customer outcomes by industry, and nothing here is clinical or regulatory advice.
What sets device selling apart
A device rep sells inside a hospital that controls access to its own people. The clinical conversation happens with surgeons and nurses. The economic conversation happens with supply chain and finance, often against a group purchasing contract. The decision happens in a committee that may never meet the rep.
Symplr's guide to the hospital committee puts it simply: as committees take hold, the rep's goal moves from building relationships with the physicians who use the product to demonstrating the product's case to the committee. A paper in Clinical Orthopaedics and Related Research by David Kalainov defines value for these committees as quality divided by cost. Both halves of that ratio need evidence, and the rep has to collect it.
What to coach, stage by stage
| Stage | Coach on the live deal | Ready when |
|---|---|---|
| Buying group | Who sits on the value analysis committee and what each seat will ask | Each seat named with its likely question and the evidence that answers it |
| Cycle length | The committee calendar and the submission deadline | The rep knows the meeting date, the deadline and who sponsors the request |
| Missing evidence | The cost side: what the current product or procedure costs the hospital | A cost the buyer stated, from supply chain or finance |
| Method | Discovery that separates the clinical case from the economic one | The rep can state both cases in the buyer's words |
The surgeon is the champion and the committee decides
A surgeon's enthusiasm is the start of a deal. Symplr lists the usual committee members as physicians, nurses, administrators, supply chain specialists, risk specialists and purchasing agents, and notes that for approval the rep must show it makes sense both financially and clinically. A surgeon cannot answer the financial half.
Coach who will sit on the committee for this product, who will sponsor it, and what each member will ask. The manager listens for a rep who has only spoken to clinicians. The questions in discovery call questions on approvals and decision process apply here, asked of the surgeon and then of supply chain.
A rep in good shape has asked the surgeon who sponsors new product requests and has a call booked with the value analysis coordinator.
The cycle runs on the committee calendar
Device deals run long because committees meet on a schedule and submissions close before each meeting. A rep who misses a submission deadline can lose a month or more waiting for the next meeting. Forecasting a device deal without the committee date is forecasting a hope.
The manager pins down the committee date, the submission deadline, the sponsor, and the documents the committee asks for. The manager works backwards from the meeting with the rep and agrees which evidence the rep will gather on which call.
When that is done, the deal record has a committee date, a sponsor's name and a list of documents with owners.
What device deals are missing most often
The common gap is the cost side of the case. Reps carry deep clinical knowledge and can discuss outcomes data at length. Fewer ask what the hospital spends today on the current device, the extra theater time, the readmissions or the reprocessing. Without that, the committee weighs a price increase against a clinical claim, and supply chain has no reason to move.
The manager asks what the buyer has said the current approach costs, and who said it. If no one has, the manager works the question the rep will ask supply chain or the department finance lead on the next call.
What counts is a cost in the buyer's own words, from someone who sits on or reports to the committee.
Two cases: clinical and economic
Device teams that run a named method get more from it here than almost anywhere. Gap Selling's current state and future state map well onto a procedure today and a procedure with the device. MEDDPICC's metrics and decision process cover the committee. The ValueSelling Framework® separates the buyer's view of value from the price. Our method pages describe each in its own terms: Gap Selling, MEDDPICC, ValueSelling.
In review, the manager looks for which element of the method is weakest on this deal and which committee seat it affects.
The rep should be able to say, in one sentence each, the clinical case and the economic case, and who has confirmed each.
Example: Lena's stapler deal (illustrative)
This deal is made up. Lena sells a single-use surgical stapler into a 400-bed hospital. An orthopedic surgeon has used it on three cases during an evaluation and wants it on contract. Lena has the deal in "evaluation complete".
- Next two callsSponsor and cost questions
- The surgeon agrees to sponsor
- Supply chain names the reprocessing contract
- In two weeksSubmissions close
- In five weeksThe committee meets
- The clinical and the economic case
The call with Caty. Lena gets on a call with Caty and describes the deal. Caty asks who sponsors the request to the committee. Lena assumes the surgeon. Caty asks what the current stapler costs the hospital, per case and in total. Lena knows the list price but has never asked what the hospital spends. Caty asks when the committee meets. She does not know.
What Caty finds. Strong clinical evidence and no economic case, no sponsor, no date. Caty works her next two calls with her. With the surgeon: confirm he will sponsor the request and ask who on the committee will push back. With the supply chain manager: ask what the hospital spends on the current product and on reprocessing, and when the next submission closes.
The next calls. The surgeon agrees to sponsor. The supply chain manager says the committee meets in five weeks and submissions close in two, then gives the hospital's yearly spend on reprocessing the current stapler, a contract that is up for renewal. That spend is the cost Lena needed. Her submission now carries both halves of the case.
Which skills to coach first
Medtech reps usually arrive strong on product knowledge, so the gaps are in the conversation. Start with two: framing the economic problem in the hospital's terms, and getting a sponsor to commit to a date. Lena's deal stalled on both. A rep who can say "reprocessing the current stapler costs you this much a year" to supply chain, and then ask the surgeon "will you put this in front of the committee before the next submission deadline?", has covered most of what the committee needs.
To check discovery on your team's recorded calls, including the moment each one turned into a pitch, talk to us. When the committee or supply chain pushes back on price, objection handling covers the response.
Building a medical device sales training program around live deals
A medical device sales training program usually starts with product, anatomy and procedure training, and it should. A rep cannot sell a device they cannot explain to a surgeon. The program falls short when it stops there, because the committee questions only show up on a live deal.
A program that carries into the field has three layers:
- Product and clinical training, delivered at launch or onboarding, with certification where the company requires it.
- Committee practice. Before a rep's first committee deal, the rep rehearses the economic conversation with supply chain in a roleplay built from that deal, then debriefs it.
- Deal coaching. Every committee deal gets a review on a call before the submission deadline, worked through the stage table above.
This example is illustrative. A new rep certifies on the stapler in week two, rehearses a supply chain conversation about reprocessing costs in week four, and brings her first live deal to a review before its submission closes.
Coaching on existing accounts and contract renewals
Much of a device rep's year goes into accounts the company already has. A product on contract can still be lost at renewal, to a group purchasing agreement, a cheaper alternative the committee reviews, or a price increase the hospital will not absorb.
Coach a renewal the way you coach a new deal, with the committee in mind. Ask the rep what the hospital has gained since the product went on contract, in the hospital's own terms, and who at the hospital has said so. Ask when the contract comes up for review and who will raise it at the committee. A rep who only knows the surgeon still likes the product has the same gap as on a new deal: the clinical case without the economic one.
A price increase is the hardest conversation in an existing account. Rehearse it before it happens, in a roleplay built from that account, with supply chain's likely pushback, and debrief it against the cost evidence the rep has.
The renewal is in good shape when the rep can name the review date, the person who will speak for the product and a cost or outcome the hospital has confirmed since the last contract.
Coaching every device deal
A regional device manager covers reps across hundreds of miles and dozens of accounts, and spends much of the week in hospitals. Coaching every rep on every committee deal is not possible for one person.
Our AI sales experts give every rep that preparation. A deal review is a call: the rep describes the deal out loud, Caty asks what the committee will need and what is missing, and prepares the next conversation in the team's method. Typing works when the rep is between cases and cannot talk. Managers get a read across the team.
Talk to us with a committee date coming up.
FAQ
How do you coach medical device sales reps?
Coach the live deal through the hospital's decision. For each deal, ask who sponsors it to the value analysis committee, when the committee meets, and what the hospital spends today. Then prepare the rep's next calls with surgeons and supply chain so both the clinical and the economic case reach the committee.
What is a value analysis committee in medical device sales?
A value analysis committee is a hospital group that decides which products to buy by weighing clinical evidence against cost. Members usually include physicians, nurses, administrators, supply chain and purchasing. For a device rep it is the decision point, and its members need evidence the surgeon cannot give.
Why do medical device deals stall after a successful evaluation?
Most stall because the rep has the clinical case and not the economic one, or because no one has sponsored the request to the committee before the submission deadline. A surgeon's approval starts the purchase. The hospital's committee calendar, sponsor and cost evidence decide when it happens.
What skills matter most in medtech sales?
The skills that matter most in medtech sales are discovery on the economic case, framing the problem in the hospital's terms and getting a sponsor and a date committed. These come on top of product and clinical knowledge. Most device reps already know the product well, so these are where deals are won or lost.
Can AI coach medical device reps?
AI can coach medical device reps on their live deals. An AI coach can run a deal review as a call: the rep talks through the account, the coach asks about the sponsor, the committee date and the cost evidence, and prepares the next conversation. It does not replace clinical training, compliance review or the manager's judgment on the account.